Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Achieve Life Sciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +8 vs. Q1 2023
- Shares held
- 3.57M
- +1.10M (+44.7%) vs. Q1 2023
- Total value
- $18.6M
- +$1.97M (+11.9%) vs. Q1 2023
- New holders
- 11
- 14 more added
- Sold out
- 3
- 10 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 166 | $862 | 0.00% | −560−77.1% | Reduced |
| Cutler Group LP | 479 | $2.00K | 0.00% | −621−56.5% | Reduced |
| Godsey & Gibb Associates | 453 | $2.35K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 500 | $3.00K | 0.00% | +500 | New |
| Simplex Trading, LLC | 2,057 | $10.0K | 0.00% | +530+34.7% | Added |
| Stephens Consulting, LLC | 3,000 | $15.6K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 3,800 | $19.7K | 0.00% | 00.0% | Unchanged |
| Belvedere Trading LLC | 4,163 | $21.6K | 0.01% | −5,750−58.0% | Reduced |
| Advisor Group Holdings, Inc. | 4,452 | $23.1K | 0.00% | +1,909+75.1% | Added |
| BerganKDV Wealth Management, LLC | 5,000 | $25.9K | 0.00% | +5,000 | New |
| Bank of America Corp | 6,519 | $33.8K | 0.00% | +6,519 | New |
| CVI Holdings, LLC | 11,200 | $58.1K | 0.06% | +11,200 | New |
| Bank of New York Mellon Corp | 11,441 | $59.4K | 0.00% | −231−2.0% | Reduced |
| Manchester Financial Inc | 12,925 | $67.1K | 0.02% | +12,925 | New |
| Group One Trading, L.P. | 13,606 | $70.6K | 0.00% | −123,640−90.1% | Reduced |
| Citadel Advisors LLC | 14,689 | $76.2K | 0.00% | +12,196+489.2% | Added |
| XTX Topco Ltd | 14,841 | $77.0K | 0.01% | +14,841 | New |
| Beaumont Financial Advisors, LLC | 12,000 | $81.6K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 19,438 | $100.9K | 0.00% | +15,792+433.1% | Added |
| Squarepoint Ops LLC | 21,972 | $114.0K | 0.00% | +21,972 | New |
| Prelude Capital Management, LLC | 26,992 | $140.1K | 0.01% | +11,772+77.3% | Added |
| Renaissance Technologies LLC | 39,600 | $206.0K | 0.00% | −2,000−4.8% | Reduced |
| BlackRock Inc. | 52,585 | $272.9K | 0.00% | +39,731+309.1% | Added |
| State Street Corp | 63,316 | $328.6K | 0.00% | +35,900+130.9% | Added |
| Northern Trust Corp | 73,578 | $381.9K | 0.00% | +41,673+130.6% | Added |
| Diametric Capital, LP | 84,078 | $436.4K | 0.19% | +37,679+81.2% | Added |
| EAM Investors, LLC | 91,963 | $477.3K | 0.09% | +91,963 | New |
| Walleye Capital LLC | 95,033 | $493.2K | 0.01% | +69,960+279.0% | Added |
| One68 Global Capital, LLC | 96,700 | $501.9K | 3.06% | +96,700 | New |
| Wells Fargo & Company | 122,493 | $635.7K | 0.00% | −2,030−1.6% | Reduced |
| Perkins Capital Management Inc | 126,212 | $655.0K | 0.57% | −11,000−8.0% | Reduced |
| Raymond James & Associates | 137,485 | $713.5K | 0.00% | +33,203+31.8% | Added |
| LPL Financial LLC | 148,000 | $768.1K | 0.00% | +4,100+2.8% | Added |
| Geode Capital Management, LLC | 162,288 | $842.3K | 0.00% | −18,195−10.1% | Reduced |
| National Asset Management, Inc. | 216,216 | $1.12M | 0.03% | +216,216 | New |
| Long Focus Capital Management, LLC | 248,099 | $1.29M | 0.20% | −65,121−20.8% | Reduced |
| AWM Investment Company, Inc. | 272,500 | $1.41M | 0.19% | +272,500 | New |
| Vanguard Group Inc | 577,793 | $3.00M | 0.00% | +158,409+37.8% | Added |
| Shay Capital LLC | 776,600 | $4.03M | 1.42% | +296,600+61.8% | Added |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −174,714−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −250−100.0% | Sold out |